Mankind Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE634S01028
  • NSEID: MANKIND
  • BSEID: 543904
INR
2,660.00
30 (1.14%)
BSENSE

Nov 20

BSE+NSE Vol: 4.74 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Mankind Pharma
Laurus Labs
Aurobindo Pharma
Zydus Lifesci.
Torrent Pharma
Dr Reddy's Labs
Glenmark Pharma
Cipla
Alkem Lab
Lupin
Biocon
Why is Mankind Pharma Ltd ?
1
High Management Efficiency with a high ROCE of 23.22%
2
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 0.58 times
3
Healthy long term growth as Net Sales has grown by an annual rate of 17.71%
4
With a growth in Net Profit of 37.57%, the company declared Very Positive results in Sep 26
  • The company has declared positive results for the last 3 consecutive quarters
  • OPERATING CF(Y) Highest at Rs 2,751.99 Cr
  • OPERATING PROFIT TO INTEREST(Q) Highest at 11.16 times
  • PBT LESS OI(Q) Highest at Rs 834.26 cr.
5
Stock is technically in a Bullish range
  • The technical trend has improved from Mildly Bullish on 16-Nov-26 and has generated 1.33% returns since then
  • The stocks MACD and Bollinger Band technical factors are also Bullish
6
High Institutional Holdings at 24.93%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
stock-recommendationReal-Time Research Report
Verdict Report
How much should you buy?
  1. Overall Portfolio exposure to Mankind Pharma should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Mankind Pharma for you?

Medium Risk, High Return

Absolute
Risk Adjusted
Volatility
Mankind Pharma
18.91%
0.66
28.86%
Sensex
-2.0%
-0.13
14.98%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
17.71%
EBIT Growth (5y)
19.92%
EBIT to Interest (avg)
32.15
Debt to EBITDA (avg)
1.33
Net Debt to Equity (avg)
0.16
Sales to Capital Employed (avg)
0.77
Tax Ratio
21.04%
Dividend Payout Ratio
2.16%
Pledged Shares
0
Institutional Holding
24.93%
ROCE (avg)
20.02%
ROE (avg)
15.82%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
47
Industry P/E
40
Price to Book Value
6.25
EV to EBIT
35.56
EV to EBITDA
27.65
EV to Capital Employed
5.52
EV to Sales
7.33
PEG Ratio
1.37
Dividend Yield
NA
ROCE (Latest)
15.51%
ROE (Latest)
13.36%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

22What is working for the Company
OPERATING CF(Y)

Highest at Rs 2,751.99 Cr

OPERATING PROFIT TO INTEREST(Q)

Highest at 11.16 times

PBT LESS OI(Q)

Highest at Rs 834.26 cr.

DPS(Y)

Highest at Rs 1.00

DPR(Y)

Highest at 2.03%

NET SALES(Q)

Highest at Rs 4,337.86 cr

PBDIT(Q)

Highest at Rs 1,171.25 cr.

PAT(Q)

Highest at Rs 711.48 cr.

EPS(Q)

Highest at Rs 17.23

-2What is not working for the Company
DEBTORS TURNOVER RATIO(HY)

Lowest at 7.06 times

Loading Valuation Snapshot...
Here's what is working for Mankind Pharma
Operating Profit to Interest - Quarterly
Highest at 11.16 times and Grown
each quarter in the last five quarters
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Operating Cash Flow - Annually
Highest at Rs 2,751.99 Cr and Grown
each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 834.26 cr. and Grown
each quarter in the last five quarters
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 834.26 cr has Grown at 41.0% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 591.87 Cr
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Net Sales - Quarterly
Highest at Rs 4,337.86 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 1,171.25 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 711.48 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 711.48 cr has Grown at 32.4% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 537.25 Cr
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 17.23
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)

Dividend per Share (DPS) - Annually
Highest at Rs 1.00
in the last five years
MOJO Watch
Company is distributing higher dividend from profits generated

DPS (Rs)

Dividend Payout Ratio (DPR) - Annually
Highest at 2.03%
in the last five years
MOJO Watch
Company is distributing higher proportion of profits generated as dividend

DPR (%)

Here's what is not working for Mankind Pharma
Debtors Turnover Ratio- Half Yearly
Lowest at 7.06 times
in the last five half yearly periods
MOJO Watch
Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio